Crossmark

Can AI-based body composition assessment outperform body surface area in predicting dose-limiting toxicities for colonic cancer patients on chemotherapy?

Crossref DOI link: https://doi.org/10.1007/s00432-023-05227-7

Published Online: 2023-08-04

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cao, Ke

Yeung, Josephine

Arafat, Yasser

Choi, CheukShan

Wei, Matthew Y. K.

Chan, Steven

Lee, Margaret

Baird, Paul N.

Yeung, Justin M. C.
Funding

Funding for this research was provided by:

University of Melbourne
License Information

Text and Data Mining valid from 2023-08-04

Version of Record valid from 2023-08-04
More Information

Article History

Received: 14 June 2023

Accepted: 28 July 2023

First Online: 4 August 2023

Declarations

:

: The authors declare no competing interests.

: The authors have no relevant financial or non-financial interests to disclose.

: This study was approved by the Ethics Department at the Western Health Office for Research (Project QA2020.24_63907). The protocol followed the tenets of the Declaration of Helsinki and all privacy requirements were met.

: The ethical application approves a waiver of consent.

Document is current

Any future updates will be listed below